Aptose Biosciences Inc (APTO)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
William G. Rice
Employees:
40
251 CONSUMERS ROAD, SUITE 1105, TORONTO, A6, M2J 4R3
647-479-9828
-
Formally known as:
- APTOSE BIOSCIENCES, INC. ORDINARY
- APTOSE BIOSCIENCES, INC. ORDINARY
- Lorus Therapeutics, Inc.
Date | Ratio |
---|---|
2010-06-01 | 1:3 |
2014-10-06 | 1:12 |
Aptose Biosciences discovers and develops personalized therapies addressing unmet medical needs in oncology. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and HR MDS. The company also develops luxeptinib, a dual bromodomain and extra-terminal domain motif motif motif protein and kinase inhibitor program.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|